Hepatitis Vaccination and Prophylaxis

descriptionPublicationkeyboard_double_arrow_right Article 01 May 2009 English Publisher:Elsevier BVJournal:Clinics in Liver Disease, volume 13, pages 317-329 (issn: 1089-3261,

Copyright policy )

Authors: Carolyn T, Nguyen; Tram T, Tran;

doi: 10.1016/j.cld.2009.02.005

pmid: 19442921

Hepatitis Vaccination and Prophylaxis

- Summary
- Subjects
- Metrics

Abstract

The three most commonly identified causes of viral hepatitis in the United States are hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV). Hundreds of millions of people worldwide are infected by these viruses; many experience illness as a result. This article discusses current recommendations for vaccination and other forms of prophylaxis aimed at minimizing the clinical effects of these viruses.

Related Organizations

Cedars-Sinai Medical Center
United States
University of California, Los Angeles
United States

Keywords

Adult, Hepatitis A Vaccines, Vaccination, Immunization, Passive, Immunoglobulins, Infant, Hepatitis A, Hepatitis B, Humans, Hepatitis B Vaccines, Hepatitis B Antibodies

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	8
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average